As India moves towards Viksit Bharat 2047, the healthcare growth story must also answer a difficult question: can a basic necessity remain within reach for ordinary families?
By Gulamaly Hussain Every Independence Day, we speak of India’s progress with pride. We speak of growth, ambition, infrastructure, technology, entrepreneurship and the promise of a Viksit Bharat by 2047. But true progress must also be measured by something far more personal: whether an ordinary family can access quality healthcare without fear of financial ruin.
Healthcare has always been a basic human necessity. Yet for many Indians, quality treatment today increasingly feels like a financial decision before it becomes a medical one. The uncomfortable truth is that many families do not fear illness alone; they fear the hospital bill that may follow.
This is not to dismiss the growth of India’s healthcare sector. The sector has expanded significantly, and private capital has played an important role in that expansion. Hospitals, diagnostics, healthtech, insurance, pharma services, medical devices and preventive care are all attracting investment because the need is real and structural.
India clearly needs this capital. It needs more hospitals, better diagnostics, stronger insurance models, wider digital health adoption, medical innovation and improved services outside the largest cities. The real question is not whether healthcare should attract investment. It should. The more important question is what kind of healthcare growth that investment enables.
For investors, this is not a soft concern. It is a market signal. Healthcare companies that can reduce friction in access, improve pricing transparency, use technology to lower delivery costs, and build trust across patient groups may create more durable value than businesses that depend only on premium pricing. In a sector where reputation, regulation and patient experience are closely linked, affordability can become a long-term business advantage.
The scale of the opportunity is also clear. India Brand Equity Foundation has cited projections that India’s healthcare sector could reach US$320 billion by 2028. The number reflects the depth of demand, but it also raises a sharper question: will this growth broaden access, or will it make quality care feel even more distant for those outside the premium segment?
This balance matters more today because medical costs are still a direct household burden for many. The National Health Accounts Estimates for India 2022-23 placed out-of-pocket expenditure at 43.4% of total health expenditure. Media reports based on the same data noted that this marked a rise from 39.4% in FY22. Out-of-pocket spending is not just a statistic. It is the money a household pays at the moment of need. For many families, it can mean savings being drained, assets being sold, or treatment being delayed.
Healthcare inflation and insurance affordability are also becoming sharper market concerns. Reuters recently reported that India is weighing health insurance reforms to improve transparency and rein in costs, against the backdrop of medical inflation estimated by industry sources at roughly 12% to 14% annually. When policy, insurance and patient affordability start converging in the same discussion, investors should see it as more than a regulatory footnote.
From an investor’s point of view, affordability should not be seen as charity. It is a sustainability metric. A healthcare business that becomes unaffordable for a large section of the population may eventually face reputational risk, regulatory pressure, insurance disputes and loss of public trust. In a sector built around human vulnerability, trust is not soft value. It is enterprise value.
Healthcare also cannot be evaluated like an ordinary consumer business. A patient is not simply a customer comparing brands. A patient is often anxious, dependent on expert advice and under pressure to make quick decisions. This makes transparency, ethical communication, clinical governance and fair pricing far more important than in many other sectors.
For investors, due diligence in healthcare must therefore go beyond revenue, margins, expansion plans and bed capacity. It must also examine billing practices, patient communication, claims behaviour, compliance culture, clinical governance and the ability of a business to scale without losing public confidence.
India’s deeper healthcare opportunity may not lie only in building more premium facilities in major cities. It lies in creating trusted, scalable and accessible models that serve Tier 2 and Tier 3 markets as well. Diagnostics networks, healthtech platforms, preventive care, chronic disease management, medical devices, affordable insurance and healthcare financing can all play a meaningful role if they are built with the right intent and governance.
For healthcare founders and operators, the message is equally clear. Growth alone will not be enough. The next phase will demand clean reporting, transparent pricing, responsible communication and stronger patient trust. Companies that can show both commercial strength and social relevance will be better positioned for long-term capital.
On Independence Day, the conversation around freedom should not remain limited to history or symbolism. It should also extend to the everyday anxieties that shape people’s lives. Freedom from healthcare insecurity is one such unfinished promise.
India’s healthcare sector can grow as a powerful investment opportunity. It can also remain a public good. The real responsibility is to make sure one does not weaken the other.
A developed India cannot be built only on larger markets and bigger valuations. It must also be built on systems that ordinary citizens can trust when they are most vulnerable. Healthcare can be a business, but affordability must not become the casualty of that business.
